"Life in the Community" sculpture outside of CMS headquarters in Baltimore.

Will New Administration Reverse Deep Medicare Part B Cuts to 340B Hospitals?

The U.S. Centers for Medicare & Medicaid Services (CMS) Tuesday asked the White House to review a hospital payment proposed rule for next year that will either keep, end, or change the nearly 30 percent cut since 2018 in Medicare Part B drug reimbursement for hospitals’ 340B-purchased drugs.

CMS on May 11 sent its calendar year 2022 hospital outpatient prospective payment (OPPS) payment rates and policy changes proposed rule to the Office of Management and Budget (OMB) for approval to be published in the Federal Register. Compared with recent years’ OPPS proposed rules, OMB is getting this one from CMS for review sooner than normal. Last year, CMS released the calendar year 2021 proposed rule for public comment on Aug. 4. Signs point to the new proposed rule being released in July.

The U.S. Centers for Medicare & Medicaid Services (CMS) Tuesday asked the White House to review a hospital payment proposed rule for next year that will either keep, end, or change the nearly 30 percent cut since 2018 in Medicare Part B drug reimbursement for hospitals’ 340B-purchased drugs.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report